Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Oakmark U.S. Large Cap ETF (OAKM) and Columbia Research Enhanced Value ETF (REVS) belong to the same industry segment: US Large Cap Value. OAKM's top 3 sector exposures are Financials, Energy and Health Care. In contrast, REVS's top sector exposures are Financials, Health Care and Industrials. OAKM is more expensive with a Total Expense Ratio (TER) of 0.64%, versus 0.19% for REVS. OAKM is down -2.47% year-to-date (YTD) with +$147M in YTD flows. REVS performs better with 2.51% YTD performance, and +$74M in YTD flows. Run a side-by-side ETF comparison of OAKM and REVS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | OAKM REVS | -4.49%-3.72% | -0.37%+3.44% | -2.47%+2.51% | +15.34%+18.51% | n/a+57.22% | n/a+75.71% |
| Flows | OAKM REVS | -$41M+$13M | +$212M+$79M | +$147M+$74M | +$817M+$138M | -+$173M | -+$193M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | OAKM REVS | +15.01%+11.36% | +18.29%+16.05% | n/a+13.41% | n/a+15.12% |
| Max drawdown | OAKM REVS | -4.89%-3.82% | -13.48%-12.32% | n/a-16.16% | n/a-17.78% |
| Max drawdown duration | OAKM REVS | 60d28d | 46d46d | n/a211d | n/a448d |
OAKM | REVS | |
Last sale 3/11/2026 at 1:30 PM | $27.38 | $28.72 |
| Previous close 03/10/2026 | $27.33 | $28.81 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
OAKM | REVS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
OAKM | REVS | |
|---|---|---|
| Last price | $27.38 | $28.72 |
| 1D performance | +0.18% | -0.30% |
| AuM | $1.06 B | $214.92 M |
| E/R | 0.64% | 0.19% |
OAKM | REVS | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Oakmark Funds | Columbia Threadneedle Investments |
| Benchmark | - | Beta Advantage Research Enhanced U.S. Value Index |
| N° of holdings | 36 | 281 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 2, 2024 | September 25, 2019 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
